Tissue Therapies
HOME TECHNOLOGY INVESTORS ALLIANCES COMPANY
CONTACT




HOME COMPANY THE BOARD MEL BRIDGES   
MEL BRIDGES :: NON-EXECUTIVE DIRECTOR


BSc (Chemistry), FAICD
Mr Bridges has extensive experience as a CEO and Company Director in healthcare, agricultural technology, drug development, pathology, diagnostics and medical devices.


Has successfully raised in excess of $300M investment capital in the healthcare/biotech sector and been directly involved in over $1B in merger and acquisition and related transactions.


Mr Bridges is current or past Chairman of Alchemia Limited and ImpediMed Limited, Director of Benitec Limited, Campbell Brothers Limited and Genera Biosystems Limited.




© 2007 TISSUE THERAPIES LTD